Downregulation of Id2 increases chemosensitivity of glioma

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
ZhenYu ZhaoXinguang Yu

Abstract

With its growth characteristic and chemoresistance, glioblastoma is the most deadly brain tumor. Twenty-five core genes that influence the chemosensitivity of glioblastoma were screened in our previous experiments, and Id2, the inhibitor of DNA binding 2, an oncogene encoding a helix-loop-helix protein, was identified. The elevated expression levels of Id2 have been reported in several malignancies. The aim of this study is to investigate the effects of Id2 expression on the chemosensitivity of glioma cells. In this study, Id2 expression was investigated in a malignant glioma cell line. Then, we silenced the expression of Id2 with the highly specific posttranscriptional suppression of RNA interference (RNAi) in U87 cells. The changes in response to antitumor agents Me-CCNU, VM26, and TMZ were evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Apoptosis was measured using an annexin V-fluorescein isothiocyanate (FITC) apoptosis detection kit. The relationship between Id2 expression and caspase 3 was tested by RT-PCR and Western blot. This study demonstrated that Id2 was significantly upregulated in glioma tissues, and Id2 correlated well with the advancement of glioma grade and a worse prognos...Continue Reading

References

Aug 15, 1997·The Biochemical Journal·G M Cohen
Apr 26, 2000·British Journal of Cancer·E Galanis, J Buckner
Jan 25, 2002·Journal of Cellular Physiology·Yoshifumi Yokota, Seiichi Mori
Feb 8, 2002·Cell·Ricky W JohnstoneScott W Lowe
Oct 31, 2003·Lancet·Nathan R Wall, Yang Shi
Mar 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jean-Philippe CoppePierre-Yves Desprez
Apr 16, 2005·Molecular and Cellular Biology·Anna LasorellaAntonio Iavarone
Aug 19, 2007·CNS Drugs·Brennan M R SpiegelMarc C Chamberlain
Mar 6, 2009·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·G StalloneL Gesualdo
Aug 3, 2011·Brain Research Bulletin·Zhenyu ZhaoYi-Cheng Lu
Jan 10, 2014·Nature Reviews. Molecular Cell Biology·Guillermo MariñoGuido Kroemer

❮ Previous
Next ❯

Citations

Sep 26, 2019·Biochemical Society Transactions·Jong Fu WongAlex N Bullock
Feb 2, 2020·Apoptosis : an International Journal on Programmed Cell Death·Firas KhathayerSwapan K Ray

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis